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Due to its economic impact, classical swine fever (CSF) 
ranks among the most important diseases of domestic pigs. 
Clinical and pathological signs are highly variable, and diag-
nosis must be confirmed by laboratory tests.5,16 During 
2000–2010, the polymerase chain reaction (PCR) technique 
has become more and more important for routine CSF diag-
nosis,1,3,4,13,19 and reverse transcription (RT)-PCR has been 
accepted by the European Union as an official method for 
CSF confirmation (Commission Decision 2002/106/EC). 
Meanwhile, various real-time RT-PCR methods for diagnos-
ing CSF have been described,* and the first commercial 
real-time RT-PCR kits are already available.3,11 Beside the 
published protocols, a variety of in-house protocols are also 
used. To guarantee consistent quality and diagnostic reliabil-
ity, assay protocol optimization, validation, and standardiza-
tion is needed. In this context, ring trials can help improve 
protocol standardization and harmonization. For CSF, such 
ring trials have been performed in the past.18,19
The current study reports on the results of a real-time RT-PCR 
ring trial for the detection of Classical swine fever virus 
(CSFV; family Flaviviridae, genus Pestivirus) genomic RNA 
among 10 European laboratories that are routinely involved 
in CSF diagnosis. Organized by the Friedrich-Loeffler-Institut 
(FLI; Riems Island, Germany), the trial was based on well-
characterized samples evaluated with 1 standard method by 
all participating laboratories7 in comparison to different routine 
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Abstract. The current study reports on a real-time reverse transcription polymerase chain reaction (real-time RT-PCR) 
ring trial for the detection of Classical swine fever virus (CSFV) genomic RNA undertaken by 10 European laboratories. All 
laboratories were asked to use their routine in-house real-time RT-PCR protocols and a standardized protocol commonly used 
by the Friedrich-Loeffler-Institute (FLI) on a panel of well-characterized samples. In general, all participants produced results 
within the acceptable range. The FLI assay, several in-house assays, and the commercial kits had high analytical sensitivity and 
specificity values. Nevertheless, some in-house systems had unspecific reactions or suboptimal sensitivity with only a single 
CSFV genotype. Follow-up actions involved either improvement of suboptimal assays or replacement of specific laboratory 
assays with the FLI protocol, with or without modifications. In conclusion, the ring trial showed reliability of classical swine 
fever diagnosis on an international level and helped to optimize CSFV-specific RT-PCR diagnostics.
Key words: Classical swine fever virus; polymerase chain reaction; ring trial.
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in-house protocols (published and unpublished). The aim of 
the ring trial was to evaluate the reliability of CSF real-time 
RT-PCR diagnosis on an international level, and to optimize 
CSFV-specific RT-PCR diagnostics.
To this means, a test panel was sent out comprising 48 man-
ually extracteda viral RNA samples in RNA-safe buffer (50 
ng/µl of carrier polyA-RNA,b 0.05% Tween-20,c 0.05% 
sodium azided in RNase-free water) with defined copy num-
bers including 2 negative controls. Viral RNA from CSFV 
strains of all available genotypes as well as from related pes-
tiviruses were integrated into the test panel to assess ana-
lytical specificity in terms of inclusivity and exclusivity. 
Furthermore, 3 dilution series of CSFV RNA were used to 
define differences in the analytical sensitivity. Dilution series 
were prepared from CSFV strains Alfort (genotype 1.1), 
Spante (genotype 2.3), and Kanagawa (genotype 3.4), respec-
tively. For the standardization of the ring trial, the protocol 
commonly used by the FLI7 was included (hereafter, FLI pro-
tocol). The reagents for this assay were transferred together 
with the viral RNA.
Participating laboratories were asked to use their own 
routine real-time RT-PCR protocols for CSFV detection 
(hereafter, in-house protocols, not considering whether such 
protocols were published, unpublished, or commercially avail-
able). In total, 13 additional assays were used, of which 
only 3 were unpublished. Most protocols were CSFV spe-
cific,7,11,12,14,15,20 but 3 protocols (1 unpublished) were Pestivirus 
specific.22,23 In detail, 3 laboratories used a previously pub-
lished assay,14,15 while 1 laboratory used a reference method7 
with in-house modifications, and another laboratory a differ-
ent assay.20 Two laboratories used a commercial real-time 
RT-PCR kit.e One of the laboratories combined the commer-
cial assay with an additional commercial kit.f Each of the 
Pestivirus-specific protocols was used by 1 laboratory.
Most laboratories carried out 2 runs for each method to 
obtain a final result. For the purpose of the current ring trial, 
evaluation of results was done on the basis of mean threshold 
cycle (Ct) values. In cases where only 1 run was positive or 
Ct values were higher than the internal cut-off of the respec-
tive laboratory, results were reported as inconclusive. The 
same applied for samples with increasing fluorescent values 
that did not cross the threshold. Results of the organizing 
laboratory were only used for comparison and were not 
included in the comparative evaluation.
Results indicated that CSFV samples representing differ-
ent genotypes were reliably detected in all participating labo-
ratories that used the FLI protocol (Table 1, samples 1–13). 
Using the in-house protocols, only minor problems were noticed 
in this section. One laboratory (D) reported 4 inconclusive 
results, and 1 test system did not detect 1 of the group 3 CSFV 
strains in 2 laboratories (I1 and J1). While laboratory I1 failed 
to detect CSFV strain Kanagawa, laboratory J1 did not detect 
CSFV strain Congenital tremor. Both commercial kits (labo-
ratories B and G) detected all strains included in the ring trial. 
Detailed results are presented in Table 2 (samples 1–13).
In general, neither Border disease virus (BDV) nor Bovine 
viral diarrhea virus (BVDV), or other related pestiviruses, 
caused diagnostic problems using the FLI protocol. Only 2 
laboratories (A and E) obtained a high Ct value in 1 sample 
each. Laboratory A reported high Ct values for BDV strain 
Rudolph, whereas laboratory E had a weak positive result 
for BVDV strain Grub (Table 1, samples 14–25). The results 
were not confirmed by the in-house methods employed by 
laboratories A and E.
One CSFV-specific in-house protocol had problems with 
3 out of 4 BDV isolates as well as with BVDV strain CS8644 
and Pestivirus Hobi (laboratory J1). In addition, some incon-
clusive or false-positive results with rather high Ct values 
occurred in 1 laboratory with 1 commercial test kit (B) and 
1 in-house protocol (E). Not all pestiviruses were detected 
by the Pestivirus-specific protocols (laboratories H, I2, J2). 
Details can be found in Table 2.
Using the FLI protocol, all laboratories were able to detect 
the CSFV strain Alfort dilution with 3.2 × 101 copies/µl 
working solution. Eight out of 10 participating laboratories 
also detected dilutions containing 6.4 × 100 copies/µl; an 
additional laboratory scored this dilution as inconclusive. 
Furthermore, all laboratories were able to detect the dilution 
6.4 × 100 copies/µl in the CSFV strain Spante dilution series. 
Eight out of 10 participating laboratories also scored the 1.28 
× 100 copies/µl dilution positive. Three positive results were 
reported for the highest dilution of 2.56 × 10-1 copies/µl work-
ing solution. With the CSFV strain Kanagawa dilution series, 
all laboratories were able to detect the dilution containing 1.6 
× 102 copies/µl using the reference method.8 All but 1 labora-
tory also detected the dilution with 3.2 × 101 copies/µl, and 
4 laboratories were able to detect the dilution containing 6.4 
× 100 copies/µl. One positive result with a very high Ct value 
occurred in the dilution containing 1.28 × 100 copies/µl after 
a negative result for the previous dilution. Details are given 
in Table 1 (samples 26–46).
Most in-house systems did not have problems with the 
CSFV strain Alfort dilution series. All laboratories detected 
the second dilution containing 8 × 102 copies/µl with their 
in-house systems. The third dilution, containing 1.6 × 102 
copies/µl, was detected by all but 1 assay. The fourth dilution 
(3.2 × 101 copies/µl) was detected by 11 out of 13 assays, and 
10 assays also detected the fifth dilution containing 6.4 × 100 
copies/µl. One assay scored all dilutions positive.
The CSFV strain Spante dilution series had similar results. 
All assays successfully detected the dilution containing 1.6 
× 102 copies/µl, and 11 out of 13 had positive results in the 
next dilution step as well (3.2 × 101 copies/µl). The dilution 
with 6.4 × 100 copies/µl was detected in 11 assays again, 
but 2 results were inconclusive due to negative results in the 
previous dilution and unexplainable Ct values. The sixth 
dilution step (1.28 × 100 copies/µl) was detected with 4 assays. 
Four laboratories recorded high Ct values for the highest 
dilution step containing 2.56 × 10-1 copies/µl. A compara-
tive analysis can be found in Table 2.
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Table 1. Classical swine fever virus detection: results of mean threshold cycle values obtained using the protocol routinely used by the 
Friedrich-Loeffler-Institut as reference method.*
Participant laboratories‡
Sample Species Strain Quantity† FLI A B C D E F G H I J
Analytical specificity—inclusivity
  1 CSFV, gt 1.1 C-Stamm 1 × 104 26 25 27 27 27 25 26 26 24 26 25
  2 CSFV, gt 1.1 Eystrup91 1 × 104 29 29 29 30 29 28 29 29 26 29 27
  3 CSFV, gt 1.1 Alfort187 1 × 104 28 28 29 29 29 27 27 28 26 29 26
  4 CSFV, gt 1.1 Koslov1128 1 × 104 27 27 28 29 28 27 27 27 25 28 26
  5 CSFV, gt 1.2 Brescia 1 × 104 27 27 28 28 28 26 27 27 25 28 26
  6 CSFV, gt 2.1 Schweiz II 1 × 104 27 27 28 29 28 26 29 28 27 26 27
  7 CSFV, gt 2.1 Pader 1 × 104 27 27 27 28 27 26 28 27 27 26 26
  8 CSFV, gt 2.2 Bergen 1 × 104 27 28 27 29 28 26 31 27 27 26 25
  9 CSFV, gt 2.2 D4886/82/Ro 1 × 104 27 27 27 28 28 26 28 27 27 26 24
 10 CSFV, gt 2.3 Uelzen 1 × 104 25 26 26 27 27 25 26 26 25 24 23
 11 CSFV, gt 2.3 Spante 1 × 104 25 25 26 26 26 24 25 25 23 25 23
 12 CSFV, gt 3.1 Congenital tremor 1 × 104 26 25 26 26 25 24 25 25 23 25 24
 13 CSFV, gt 3.4 Kanagawa 1 × 104 29 29 30 30 30 29 29 29 27 30 28
Analytical specificity—exclusivity
 14 BDV, gt 3 Gifhorn 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 15 BDV, gt 2 137/4 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 16 BDV, gt 1 Rudolph 1 × 104 No Ct 39 No Ct No Ct No Ct No Ct IC§ No Ct No Ct No Ct No Ct
 17 BDV, gt 4 Isard 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 18 BVDV-1 cp7 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 19 BVDV-1 NADL 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 20 BVDV-1 Grub 1 × 104 No Ct No Ct No Ct No Ct No Ct 38 No Ct No Ct No Ct No Ct No Ct
 21 BVDV-2 München2 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 22 BVDV-2 CS8644 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 23 BVDV-2 Bure 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct IC¦ No Ct No Ct No Ct No Ct
 24 Atypical pestivirus Hobi 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 25 Atypical pestivirus Giraffe H138 1 × 103 No Ct No Ct No Ct No Ct No Ct No Ct IC¦ No Ct No Ct No Ct No Ct
Analytical sensitivity
 26 CSFV, gt 1.1 Alfort187 4 × 103 29 30 29 30 30 28 30 30 29 28 28
 27 CSFV, gt 1.1 Alfort187 8 × 102 32 35 31 33 33 31 33 34 32 30 29
 28 CSFV, gt 1.1 Alfort187 1.6 × 102 34 36 34 35 34 33 35 34 34 33 31
 29 CSFV, gt 1.1 Alfort187 3.2 × 101 36 38 37 37 37 35 37 37 37 34 33
 30 CSFV, gt 1.1 Alfort187 6.4 × 100 39 40 39 39 39 37 IC 42 No Ct 38 34
 31 CSFV, gt 1.1 Alfort187 1.28 × 100 No Ct No Ct No Ct No Ct IC No Ct IC¦ No Ct No Ct No Ct No Ct
 32 CSFV, gt 1.1 Alfort187 2.56 × 10-1 No Ct No Ct No Ct No Ct No Ct No Ct IC¦ No Ct No Ct No Ct No Ct
 33 CSFV, gt 2.3 Spante 4 × 103 27 26 27 28 27 26 26 26 24 27 25
 34 CSFV, gt 2.3 Spante 8 × 102 29 29 29 30 30 28 ND 29 26 30 28
 35 CSFV, gt 2.3 Spante 1.6 × 102 31 32 32 33 32 31 31 31 29 32 30
 36 CSFV, gt 2.3 Spante 3.2 × 101 33 35 33 35 34 32 35 34 33 32 32
 37 CSFV, gt 2.3 Spante 6.4 × 100 36 37 37 37 39 35 37 35 36 34 33
 38 CSFV, gt 2.3 Spante 1.28 × 100 No Ct 40 No Ct 39 IC 36 39 38 38 36 35
 39 CSFV, gt 2.3 Spante 2.56 × 10-1 No Ct No Ct No Ct No Ct 41 No Ct IC¦ No Ct 39 37 No Ct
 40 CSFV, gt 3.4 Kanagawa 4 × 103 30 32 30 32 32 29 31 31 30 29 28
 41 CSFV, gt 3.4 Kanagawa 8 × 102 33 33 33 34 34 32 32 33 31 32 31
 42 CSFV, gt 3.4 Kanagawa 1.6 × 102 35 36 36 37 36 34 35 35 35 36 34
 43 CSFV, gt 3.4 Kanagawa 3.2 × 101 37 No Ct 38 38 39 37 37 39 37 38 35
 44 CSFV, gt 3.4 Kanagawa 6.4 × 100 39 No Ct No Ct 40 No Ct 37 38 No Ct No Ct 42 No Ct
 45 CSFV, gt 3.4 Kanagawa 1.28 × 100 No Ct No Ct No Ct No Ct No Ct No Ct No Ct 41 No Ct No Ct No Ct
 46 CSFV, gt 3.4 Kanagawa 2.56 × 10-1 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 47 Water No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 48 RSB50 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
*FLI = Friedrich-Loeffler-Institut; CSFV = Classical swine fever virus; BVDV = Bovine viral diarrhea virus; BDV = Border disease virus; IC = inconclusive; 
gt = genotype; ND = not done; Ct = threshold cycle.
†Quantity refers to the approximate copy number per µl working solution.
‡The values obtained by the organizer (FLI) are displayed in bold.
§Inconclusive based on curve shape.
¦Inconclusive result with one of the duplicates showing high Ct values, the other none.
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Table 2. Classical swine fever virus detection: results of mean threshold cycle values obtained using the in-house methods.*
Participant laboratories‡
Sample Species Strain Quantity† FLI A14 B12 C7 D14,15 E20 F G1 G2 H§ I115 I223§ J1 J222§
Analytical specificity—inclusivity
  1 CSFV, gt 1.1 C-Stamm 1 × 104 26 33 26 26 19 28 29 25 25 27 32 24 26 26
  2 CSFV, gt 1.1 Eystrup91 1 × 104 29 34 29 30 19 30 29 27 27 29 36 27 29 25
  3 CSFV, gt 1.1 Alfort187 1 × 104 28 34 29 29 20 29 29 27 28 29 34 27 29 24
  4 CSFV, gt 1.1 Koslov1128 1 × 104 27 33 29 28 21 30 28 27 28 28 34 27 27 24
  5 CSFV, gt 1.2 Brescia 1 × 104 27 33 28 28 IC 29 29 27 27 27 33 26 29 26
  6 CSFV, gt 2.1 Schweiz II 1 × 104 27 32 29 28 19 29 29 28 28 28 32 25 29 27
  7 CSFV, gt 2.1 Pader 1 × 104 27 32 28 27 19 30 29 28 28 28 32 25 29 26
  8 CSFV, gt 2.2 Bergen 1 × 104 27 30 28 28 18 29 28 28 28 26 32 25 29 26
  9 CSFV, gt 2.2 D4886/82/Ro 1 × 104 27 31 29 28 IC 29 29 28 28 27 31 25 28 26
 10 CSFV, gt 2.3 Uelzen 1 × 104 25 29 26 26 IC 28 23 26 27 24 29 24 29 24
 11 CSFV, gt 2.3 Spante 1 × 104 25 30 26 26 16 27 23 26 27 26 31 25 28 24
 12 CSFV, gt 3.1 Congenital 
tremor
1 × 104 26 29 25 27 18 33 21 25 25 26 30 34 No Ct 33
 13 CSFV, gt 3.4 Kanagawa 1 × 104 29 46 35 30 IC 30 29 32 30 31 No Ct 28 31 25
Analytical specificity—exclusivity
 14 BDV, gt 3 Gifhorn 1 × 104 No Ct No Ct No Ct No Ct No Ct IC No Ct No Ct No Ct 30 No Ct 34 32 No Ct
 15 BDV, gt 2 137/4 1 × 104 No Ct No Ct No Ct No Ct No Ct IC No Ct No Ct No Ct 28 No Ct 34 31 No Ct
 16 BDV, gt 1 Rudolph 1 × 104 No Ct No Ct IC No Ct No Ct IC No Ct No Ct No Ct 26 No Ct 29 31 27
 17 BDV, gt 4 Isard 1 × 104 No Ct No Ct 42 No Ct No Ct No Ct No Ct No Ct No Ct 24 No Ct 25 IC 33
 18 BVDV-1 cp7 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 25 No Ct 23 No Ct 26
 19 BVDV-1 NADL 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 25 No Ct 25 No Ct 24
 20 BVDV-1 Grub 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 25 No Ct 24 No Ct 26
 21 BVDV-2 München2 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 24 No Ct No Ct
 22 BVDV-2 CS8644 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 24 29 25
 23 BVDV-2 Bure 1 × 104 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 26 No Ct 24
 24 Atypical 
pestivirus
Hobi 1 × 104 No Ct No Ct IC No Ct No Ct No Ct No Ct No Ct No Ct 33 No Ct No Ct 34 No Ct
 25 Atypical 
pestivirus
Giraffe H138 1 × 103 No Ct No Ct No Ct No Ct No Ct No Ct No Ct 39 39 30 No Ct 23 No Ct 25
Analytical sensitivity
 26 CSFV, gt 1.1 Alfort187 4 × 103 29 34 30 30 21 31 30 28 29 28 35 26 30 27
 27 CSFV, gt 1.1 Alfort187 8 × 102 32 37 32 32 25 33 31 31 31 30 36 28 33 30
 28 CSFV, gt 1.1 Alfort187 1.6 × 102 34 40 34 35 IC 36 32 33 34 32 39 31 32 31
 29 CSFV, gt 1.1 Alfort187 3.2 × 101 36 42 37 38 No Ct 38 32 36 36 36 No Ct 34 36 33
 30 CSFV, gt 1.1 Alfort187 6.4 × 100 39 41 38 38 IC 40 33 38 40 No Ct No Ct 37 35 34
 31 CSFV, gt 1.1 Alfort187 1.28 × 100 No Ct No Ct No Ct No Ct IC No Ct IC¦ 39 No Ct No Ct No Ct No Ct No Ct No Ct
 32 CSFV, gt 1.1 Alfort187 2.56 × 10-1 No Ct No Ct IC No Ct No Ct No Ct No Ct 40 No Ct No Ct No Ct No Ct No Ct No Ct
 33 CSFV, gt 2.3 Spante 4 × 103 27 32 28 27 17 29 28 27 28 28 32 27 29 26
 34 CSFV, gt 2.3 Spante 8 × 102 29 34 30 30 20 31 29 30 30 30 35 29 31 29
 35 CSFV, gt 2.3 Spante 1.6 × 102 31 37 32 32 22 34 30 32 33 34 37 32 33 32
 36 CSFV, gt 2.3 Spante 3.2 × 101 33 41 35 35 25 36 31 34 35 33 No Ct 33 IC 34
 37 CSFV, gt 2.3 Spante 6.4 × 100 36 41 36 37 No Ct 38 32 36 37 IC 40 35 36 33
 38 CSFV, gt 2.3 Spante 1.28 × 100 No Ct No Ct 39 No Ct No Ct No Ct 32 39 38 No Ct No Ct No Ct IC No Ct
 39 CSFV, gt 2.3 Spante 2.56 × 10-1 No Ct No Ct IC IC No Ct IC 33 40 No Ct IC No Ct No Ct 35 33
 40 CSFV, gt 3.4 Kanagawa 4 × 103 30 No Ct 35 31 IC 31 31 34 31 30 39 26 30 27
 41 CSFV, gt 3.4 Kanagawa 8 × 102 33 No Ct 39 33 IC 34 30 35 33 42 No Ct 30 34 No Ct
 42 CSFV, gt 3.4 Kanagawa 1.6 × 102 35 No Ct 43 36 No Ct 27 31 37 36 No Ct No Ct 30 39 27
 43 CSFV, gt 3.4 Kanagawa 3.2 × 101 37 No Ct IC 38 No Ct 39 32 39 37 No Ct No Ct 36 38 29
 44 CSFV, gt 3.4 Kanagawa 6.4 × 100 39 No Ct No Ct 38 No Ct No Ct IC¦ 44 No Ct No Ct No Ct No Ct 38 No Ct
 45 CSFV, gt 3.4 Kanagawa 1.28 × 100 No Ct No Ct No Ct 40 No Ct No Ct No Ct 43 No Ct No Ct No Ct No Ct 39 No Ct
 46 CSFV, gt 3.4 Kanagawa 2.56 × 10-1 No Ct No Ct No Ct No Ct No Ct No Ct IC¦ No Ct No Ct No Ct No Ct No Ct No Ct No Ct
 47 Water No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct 39 No Ct
 48 RSB50 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct IC No Ct
*FLI = Friedrich-Loeffler-Institut; CSFV = Classical swine fever virus; BVDV = Bovine viral diarrhea virus; BDV = Border disease virus; IC = inconclusive; gt = genotype; 
ND = not done; Ct = threshold cycle.
†Quantity refers to the approximate copy number per µl working solution.
‡Coded participants with superscript figures refer to the reference list for all published protocols. The reference values obtained by the organizer FLI are displayed in bold.
§Pestivirus-specific assays.
¦Inconclusive result with one of the duplicates showing high Ct values, the other none but a curve below cut-off.
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Several in-house assays had problems with the CSFV strain 
Kanagawa dilution series (Table 2). Two assays did not detect 
any of the dilutions, and another assay picked up only the 
first dilution containing 4 × 103 copies/µl. Nevertheless, 9 assays 
detected the third (1.6 × 102 copies/µl), 8 assays the fourth 
(3.2 × 101 copies/µl), 3 assays the fifth (6.4 × 100 copies/µl), 
and 3 assays the sixth (1.28 × 100 copies/µl). Some positive 
results in higher dilution steps were not accompanied by posi-
tive results in the previous dilution steps, or Ct values did not 
correspond with further dilution. Only 1 assay had problems 
with both negative controls.
Summarizing the results of the current ring trial, all partici-
pants produced results within the acceptable range, and the 
results indicate that the real-time RT-PCR assay is a rapid 
and extremely sensitive tool for CSFV detection. Combined 
with the possibility of using RNA extraction robots and real-
time PCR machines with a 96- or 384-sample platform, high 
throughput, which is required during a crisis or outbreak 
situation, seems feasible.
In detail, the FLI protocol and several in-house assays 
(including the commercial kits) had high analytical sensitivity 
and specificity; however, some in-house systems also ampli-
fied related pestivirus RNA (unspecific reactions) or had 
suboptimal sensitivity with single CSFV genotypes (low sensi-
tivity). The main problems were encountered with CSFV strain 
Kanagawa, which belongs to genotype 3.4 and is used as an 
out-group strain in phylogenetic analyses due to its variation 
from other CSFV strains. In order to understand the apparent 
failure or inconsistent results of some protocols, further 
investigations regarding primer and probe sequences as well 
as other laboratory variables, such as machines, sample han-
dling, enzymes, and human factors, are needed. In general, 
the ring trial sample panel as well as the experiences with 
the real-time RT-PCR assays tested in the current ring trial 
can be used for further development and validation of molec-
ular diagnostic assays for the identification of CSFV and other 
pestiviruses.10
In the aftermath of the current ring trial, laboratories with 
a suboptimal protocol either improved their methods or 
replaced them with the highly sensitive and specific FLI 
method, with or without in-house modifications or use of 
commercial kits. In addition, the current study found that 
CSFV RNA is very stable in RNA-safe buffer. In conclusion, 
the current ring trial helped to optimize CSFV-specific real-
time RT-PCR diagnostics within the European Union and 
confirmed that the real-time RT-PCR assay is a reliable and 
robust tool for CSF diagnosis. Based on the presented findings, 
minimum standards for diagnostic real-time RT-PCR assays 
for CSF diagnosis can be discussed in the future.
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